Search Results

BI6727 10mg 10mg  | Purity Not Available

Adooq Bioscience

BI6727 is a highly potent and selective polo-like kinase (PLK) 1 inhibitor (enzyme IC50 = 0.87 nM, EC50 = 11-37 nM on a panel of cancer cell lines).

More Information Supplier Page

BI 2536 50mg 50mg  | Purity Not Available

Adooq Bioscience

BI 2536 is a selective inhibitor of Plk1, which inhibits Plk1 enzyme activity at low nanomolar concentrations.

More Information Supplier Page

BI 2536 5mg 5mg  | Purity Not Available

Adooq Bioscience

BI 2536 is a selective inhibitor of Plk1, which inhibits Plk1 enzyme activity at low nanomolar concentrations.

More Information Supplier Page

BI 2536 100mg 100mg  | Purity Not Available

Adooq Bioscience

BI 2536 is a selective inhibitor of Plk1, which inhibits Plk1 enzyme activity at low nanomolar concentrations.

More Information Supplier Page

BI6727 50mg 50mg  | Purity Not Available

Adooq Bioscience

BI6727 is a highly potent and selective polo-like kinase (PLK) 1 inhibitor (enzyme IC50 = 0.87 nM, EC50 = 11-37 nM on a panel of cancer cell lines).

More Information Supplier Page

BIBR 953 100mg 100mg  | Purity Not Available

Adooq Bioscience

BIBR 953 (Dabigatran, Pradaxa) is a highly selective, reversible, and potent thrombin inhibitor and is orally available as the prodrug, dabigatran etexilate. It has shown antithrombotic efficacy in animal models of thrombosis, with a rapid onset of action and predictable pharmacodynamic response.

More Information Supplier Page

BIBR 953 10mg 10mg  | Purity Not Available

Adooq Bioscience

BIBR 953 (Dabigatran, Pradaxa) is a highly selective, reversible, and potent thrombin inhibitor and is orally available as the prodrug, dabigatran etexilate. It has shown antithrombotic efficacy in animal models of thrombosis, with a rapid onset of action and predictable pharmacodynamic response.

More Information Supplier Page